Synaptrix Labs develops non-invasive brain–computer interface (BCI) technologies designed to enable individuals with paralysis to control assistive devices. The company’s platform includes the Neuralis™ headset, which records neural activity, and the NeuroDiffusion™ neural-decoding software that translates brain signals into actionable commands. Its approach emphasizes real-time control and accessibility without requiring surgical implantation. Synaptrix Labs positions its technology within assistive neurotechnology and rehabilitation contexts.

The technology captures EEG signals via the Neuralis™ headset and applies AI-driven algorithms through NeuroDiffusion™ to decode user intent. Decoded signals are then mapped to control external devices such as wheelchairs, enabling hands-free mobility. The system supports adaptive learning to improve accuracy and responsiveness over time. This approach emphasizes non-invasiveness, real-time operation, and user-specific calibration.

Synaptrix Labs targets individuals with severe motor impairments who require assistive technologies for mobility and independence. The platform is intended for use in clinical, rehabilitative, and home settings under supervised deployment. Its positioning reflects broader efforts to make non-invasive BCIs practical and reliable for restoring functional autonomy in people with paralysis.